NEW YORK (GenomeWeb) – Tempus and the University of Michigan's Comprehensive Cancer Center have announced a collaboration aimed at identifying the most effective care for breast cancer patients by analyzing molecular data related to in vitro biological models.

"While progress has been made in the battle against breast cancer, there are still too many unknowns that put the lives of those diagnosed at risk," Tempus Cofounder and CEO Eric Lefkofsky said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.